العربية
Health

SFDA approves registration of 'Jascayd' for treatment of idiopathic pulmonary fibrosis

The Saudi Food and Drug Authority (SFDA) has approved the registration of Jascayd (nerandomilast) for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF)

Read the full article at Saudi Gazette

More on this topic

Health

UN Human Rights Chief ‘Appalled’ by Attacks on Airports Saudi Arabia

United Nations High Commissioner for Human Rights Volker Türk condemned on Monday the repeated attacks carried out by the Houthis on airports in Saudi Arabia. “I am appalled by the repeated attacks over the past few days by the Houthis on airports in Saudi Arabia, which have killed and injured dozens of Saudis and foreign nationals, notably the horrific attack on Riyadh’s main airport,” he said in a statement.

Asharq Al-Awsat English